Jiangsu CoWin Biotech Co., Ltd. (SHA:688426)
China flag China · Delayed Price · Currency is CNY
20.40
+0.55 (2.77%)
Apr 29, 2026, 4:00 PM EDT

Jiangsu CoWin Biotech Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2018
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2018
Cash & Equivalents
161.28255.47348.341,032127.83
Upgrade
Short-Term Investments
-60.5490.01--
Upgrade
Trading Asset Securities
420.14417.04545.28402.59233.42
Upgrade
Cash & Short-Term Investments
581.42733.05983.641,434361.25
Upgrade
Cash Growth
-20.69%-25.48%-31.41%297.00%5.63%
Upgrade
Accounts Receivable
59.5443.2858.96129.6436.56
Upgrade
Other Receivables
2.2--0.31-
Upgrade
Receivables
61.7343.2858.96129.9536.56
Upgrade
Inventory
48.7745.8732.0452.5332.62
Upgrade
Other Current Assets
341.5111.2110.0410.057.72
Upgrade
Total Current Assets
1,033833.41,0851,627438.16
Upgrade
Property, Plant & Equipment
342.02381.13394.39246.43159.44
Upgrade
Long-Term Investments
29.35296.81256.71--
Upgrade
Goodwill
1.081.08-4.27-
Upgrade
Other Intangible Assets
48.8149.9729.7729.3530.15
Upgrade
Long-Term Deferred Tax Assets
27.1832.529.8317.114
Upgrade
Long-Term Deferred Charges
12.620.7324.811.3613.82
Upgrade
Other Long-Term Assets
2.32.522.0420.063.2
Upgrade
Total Assets
1,4971,6181,8221,955648.77
Upgrade
Accounts Payable
19.3931.8647.5344.0710.55
Upgrade
Accrued Expenses
12.8518.5116.6921.6922.12
Upgrade
Short-Term Debt
46.01---
Upgrade
Current Portion of Long-Term Debt
5.91----
Upgrade
Current Portion of Leases
-12.1213.659.055.67
Upgrade
Current Income Taxes Payable
0.9--9.568.21
Upgrade
Current Unearned Revenue
25.019.634.485.7510.28
Upgrade
Other Current Liabilities
65.872.513.033.58
Upgrade
Total Current Liabilities
74.078484.8693.1560.41
Upgrade
Long-Term Leases
4.549.7119.3131.7234.33
Upgrade
Long-Term Unearned Revenue
52.5330.2530.1129.585.67
Upgrade
Long-Term Deferred Tax Liabilities
7.217.758.329.10.06
Upgrade
Other Long-Term Liabilities
0.120.090.060.050.04
Upgrade
Total Liabilities
138.47131.79142.67163.6100.51
Upgrade
Common Stock
112.49112.49112.2393.5269.87
Upgrade
Additional Paid-In Capital
1,3911,3941,3911,393344.45
Upgrade
Retained Earnings
-104.542.87160.08293.13133.87
Upgrade
Treasury Stock
-47.67-43.66---
Upgrade
Comprehensive Income & Other
0.30.330.30.270.07
Upgrade
Total Common Equity
1,3511,4661,6641,780548.26
Upgrade
Minority Interest
7.1820.5615.8811.31-
Upgrade
Shareholders' Equity
1,3581,4861,6801,792548.26
Upgrade
Total Liabilities & Equity
1,4971,6181,8221,955648.77
Upgrade
Total Debt
14.4527.8432.9540.7739.99
Upgrade
Net Cash (Debt)
566.96705.21950.681,393321.25
Upgrade
Net Cash Growth
-19.60%-25.82%-31.77%333.73%-6.07%
Upgrade
Net Cash Per Share
5.166.328.4515.003.81
Upgrade
Filing Date Shares Outstanding
108.62110.11112.49112.2383.85
Upgrade
Total Common Shares Outstanding
108.62110.11112.23112.2383.85
Upgrade
Working Capital
959.36749.41999.821,534377.75
Upgrade
Book Value Per Share
12.4413.3114.8215.866.54
Upgrade
Tangible Book Value
1,3011,4151,6341,747518.11
Upgrade
Tangible Book Value Per Share
11.9812.8514.5615.566.18
Upgrade
Buildings
-235.28234.890.660.66
Upgrade
Machinery
-207.97188.41133.1175.91
Upgrade
Construction In Progress
-0.37-110.964.81
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.